Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
Shaanxi Cuikang Pharmaceutical Technology has a strong R&D team, with strong R&D strength in plant extraction, sugars, quinolines, heterocycles, steroids and boric acids.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Abitherone acetate is a CYP17 inhibitor, which can be used in combination with prednisone to treat prostate cancer patients who have received docetaxel chemotherapy and metastasis. Abitherone acetate is a precursor drug, which can be converted into abitherone after entering the body. The latter is an androgen biosynthesis inhibitor, which exerts therapeutic effect by inhibiting the activity of CYP17 enzyme and then inhibiting androgen biosynthesis.
